showed a trendP = 0.818
While GLP-1 RAs showed a trend towards reducing all-cause mortality (OR = 0.90, 95% CI: 0.82–98, I 2 = 40%; moderate, IV) (Egger’s test P = 0.818), they significantly reduced the risk of CVD mortality (OR = 0.88, 95% CI: 0.70–97, I 2 = 18%; moderate, IV) (Egger’s test P = 0.624).